C12Y 406/01001
Aodenylate cyclase
Official title: Aodenylate cyclase (4.6.1.1)
C12Y406/01001 (Aodenylate cyclase) appears on 43 US grants and 69 published applications in this corpus.
Search patents in C12Y- Granted patents
- 43
- Published applications
- 69
- Assignees
- 44
- Inventors
- 152
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 4 |
| 2005 | 0 | 4 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 2 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 3 |
| 2014 | 1 | 2 |
| 2015 | 5 | 8 |
| 2016 | 6 | 7 |
| 2017 | 4 | 8 |
| 2018 | 7 | 4 |
| 2019 | 4 | 3 |
| 2020 | 2 | 1 |
| 2021 | 3 | 2 |
| 2022 | 0 | 3 |
| 2023 | 1 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Photoactivated adenylyl cyclase30 Dec 2025US 12,509,674 B2Hamamatsu Photonics K.K.
- VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor20 Aug 2024US 12,065,486 B2Trustees of Tufts College
- Compositions and methods for the treatment or prevention of heart failure19 Sep 2023US 11,760,987 B2The Regents of the University of California
- Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function22 Jun 2021US 11,040,091 B2The Regents of the University of California
- VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor11 May 2021US 11,001,625 B2Tufts University
- Methods and system for optogenetic stimulation of adipocytes24 Sep 2026US 2026/0284229 A1MaineHealth
- Compositions and methods for inhibiting adenylate cyclase 9 (ac9)12 Feb 2026US 2026/0043031 A1Institut de Cardiologie de Montreal
- Bacteriophage7 Aug 2025US 2025/0249085 A1Glaxosmithkline Biologicals SA
- Vhh based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor6 Feb 2025US 2025/0042978 A1Trustees of Tufts College
- Microbial cell factories producing vitamin b compounds7 Nov 2024US 2024/0368659 A1
Most cited
By later US patents
- Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated39US 5,324,731 AAmira, Inc. · 1994
- Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent24US 5,676,978 AAmira, Inc. · 1997
- Creatine analogs having antiviral activity22US 5,321,030 AAmira, Inc. · 1994
- Host cells with artificial endosymbionts19US 8,956,873 B2Bell Biosystems, Inc. · 2015
- Butanol tolerance in microorganisms9US 9,273,330 B2Butamax Advanced Biofuels LLC · 2016